These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37824045)

  • 1. Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy.
    Gigliotti BJ; Jasim S
    Endocrine; 2024 Feb; 83(2):251-258. PubMed ID: 37824045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
    Altuntaş SÇ; Hocaoğlu Ç
    Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
    Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
    Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone therapy in differentiated thyroid cancer.
    Grani G; Ramundo V; Verrienti A; Sponziello M; Durante C
    Endocrine; 2019 Oct; 66(1):43-50. PubMed ID: 31617165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach.
    Fussey JM; Khan H; Ahsan F; Prashant R; Pettit L
    Head Neck; 2017 Dec; 39(12):2567-2572. PubMed ID: 28960722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
    Mazzaferri EL; Massoll N
    Endocr Relat Cancer; 2002 Dec; 9(4):227-47. PubMed ID: 12542401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
    Do Cao C; Wémeau JL
    Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S47-52. PubMed ID: 26826483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
    Biondi B; Cooper DS
    Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Park S; Kim WG; Han M; Jeon MJ; Kwon H; Kim M; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK
    Thyroid; 2017 Sep; 27(9):1164-1170. PubMed ID: 28699428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of differentiated thyroid carcinoma during full TSH suppression: is the tumor now thyroid hormone dependent?
    Davis PJ; Hercbergs A; Luidens MK; Lin HY
    Horm Cancer; 2015 Feb; 6(1):7-12. PubMed ID: 25292307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer.
    Freudenthal B; Williams GR
    Clin Oncol (R Coll Radiol); 2017 May; 29(5):325-328. PubMed ID: 28043744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated Thyroid Cancer-Treatment: State of the Art.
    Schmidbauer B; Menhart K; Hellwig D; Grosse J
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levothyroxine suppressive therapy in differentiated thyroid cancer treatment].
    Drugda J; Čáp J; Kosák M; Gabalec F
    Vnitr Lek; 2023; 69(2):128-131. PubMed ID: 37072271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal therapy in differentiated carcinoma of the thyroid gland].
    Francia G; Davì MV; Petroziello A; Sussi PL
    Chir Ital; 1994; 46(4):56-8. PubMed ID: 7882445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
    De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
    Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-hormone therapy and thyroid cancer: a reassessment.
    Biondi B; Filetti S; Schlumberger M
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):32-40. PubMed ID: 16929364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
    Santoro AB; Vargens DD; Barros Filho Mde C; Bulzico DA; Kowalski LP; Meirelles RM; Paula DP; Neves RR; Pessoa CN; Struchine CJ; Suarez-Kurtz G
    Br J Clin Pharmacol; 2014 Nov; 78(5):1067-75. PubMed ID: 24910925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
    Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
    J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
    Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
    Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.